Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach

By Colomba Paolo   Fontana Simona   Salemi Giuseppe   Barranca Marilisa   Lo Sicco Claudia   Mazzola Maria Antonietta   Ragonese Paolo   Savettieri Giovanni   De Leo Giacomo   Alessandro Riccardo   Duro Giovanni  

International Journal of Molecular Sciences, Vol. 15, Iss. 12, 2014-12 ,pp. : 23269-23282

MDPI

Access to resources Recommend Favorite

Proteomic Analysis of Cerebrospinal Fluid in a Fulminant Case of Multiple Sclerosis

By Füvesi Judit   Hanrieder Jörg   Bencsik Krisztina   Rajda Cecilia   Kovács S. Krisztián   Kaizer László   Beniczky Sándor   Vécsei László   Bergquist Jonas  

International Journal of Molecular Sciences, Vol. 13, Iss. 6, 2012-06 ,pp. : 7676-7693

MDPI

Access to resources Recommend Favorite

Genetic Determinants of Antibody Levels in Cerebrospinal Fluid in Multiple Sclerosis: Possible Links to Endogenous Retroviruses

By Emmer Alexander   Brütting Christine   Kornhuber Malte   Staege Martin S.  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 786-786

MDPI

Access to resources Recommend Favorite

Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?

By Abdelhak Ahmed   Junker Andreas   Brettschneider Johannes   Kassubek Jan   Ludolph Albert C.   Otto Markus   Tumani Hayrettin  

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-07 ,pp. : 17565-17588

MDPI

Access to resources Recommend Favorite

Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis

By Chiba Kenji   Adachi Kunitomo  

Pharmaceuticals, Vol. 5, Iss. 5, 2012-05 ,pp. : 514-528

MDPI

Access to resources Recommend Favorite